Kymera Therapeutics, Inc. (KYMR)

Typically moves ±5.86% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-10-16 APPROXIMATE

Kymera Therapeutics, Inc. (KYMR) has a 24-report earnings history dating back to Nov 05, 2020. Its average absolute post-earnings move is ±5.86%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +11.07% (Aug 03, 2023) and its largest decline was -23.98% (May 03, 2022). The next earnings report is predicted for 2026-10-16 (approximate).

Earnings reactions

How KYMR moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.86%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 05, 2026	☀ PRE	+0.91%	open_in_new
Apr 30, 2026	☀ PRE	-0.54%	open_in_new
Feb 26, 2026	☀ PRE	+4.8%	open_in_new
Nov 04, 2025	☀ PRE	+0.32%	open_in_new
Aug 11, 2025	☀ PRE	-7.24%	open_in_new
May 09, 2025	☀ PRE	-2.27%	open_in_new
Feb 27, 2025	☀ PRE	-14.45%	open_in_new
Oct 31, 2024	☀ PRE	-3.15%	open_in_new
Aug 07, 2024	☀ PRE	-2.68%	open_in_new
May 02, 2024	☀ PRE	+0.17%	open_in_new
Feb 22, 2024	☀ PRE	+4.71%	open_in_new
Nov 02, 2023	☀ PRE	+4.59%	open_in_new
Aug 03, 2023	☀ PRE	+11.07%	open_in_new
May 04, 2023	☀ PRE	-15.08%	open_in_new
Feb 23, 2023	☀ PRE	+5.17%	open_in_new
Nov 03, 2022	☀ PRE	+7.55%	open_in_new
Aug 09, 2022	☀ PRE	-3.44%	open_in_new
May 03, 2022	☀ PRE	-23.98%	open_in_new
Feb 24, 2022	☀ PRE	+9.4%	open_in_new
Nov 10, 2021	☀ PRE	-2.62%	open_in_new
Aug 06, 2021	☀ PRE	-4.43%	open_in_new
May 06, 2021	☀ PRE	-0.63%	open_in_new
Mar 11, 2021	☀ PRE	+3.36%	open_in_new
Nov 05, 2020	☀ PRE	+8.09%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.86%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 30 →

Funds holding

$1662970306

Total value held

Buying

25 added · 4 reduced

Blackrock, Inc.

$635066535 +9.43%

State Street Corp

$313877705 +14.54%

Goldman Sachs Group Inc

$136151475 +33.65%

Ubs Group Ag

$115561789 NEW BUY

Merck & Co., Inc.

$88544161 Held

SEC Filing Types

description SCHEDULE 13G/A

16 chevron_right

description SC 13G

11 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260908	open_in_new SEC.gov
144	20260904	open_in_new SEC.gov
4	20260904	open_in_new SEC.gov
144	20260902	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
10-Q	20260805	open_in_new SEC.gov
8-K	20260805	open_in_new SEC.gov
3	20260727	open_in_new SEC.gov
4	20260727	open_in_new SEC.gov

Frequently asked about KYMR earnings

When does Kymera Therapeutics, Inc. report earnings next? expand_more

Kymera Therapeutics, Inc. (KYMR)'s next earnings date is approximate for 2026-10-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does KYMR stock move after earnings? expand_more

Over 24 reports, KYMR has moved an average of ±5.86% the session after earnings, closing higher 50.0% of the time.

What was KYMR's biggest post-earnings move? expand_more

KYMR's largest post-earnings gain on record was +11.07% on Aug 03, 2023, and its largest decline was -23.98% on May 03, 2022.

Where can I find Kymera Therapeutics, Inc.'s SEC filings? expand_more

All of Kymera Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.